Charles S. Conroy Chief Executive Officer of ARTMS Products Inc., Vancouver, British Columbia – September 10, 2019 – ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world’s most needed […]
ARTMS invited presentations in September Vancouver, September 24, 2018 /BusinessWire/ — ARTMS Products, Inc. announced today that it has been invited to present at the National Nuclear Security Administration’s 2018 Mo-99 Topical Meeting on Tuesday, September 25th and the Third International […]
First-in-class, advanced technology enables production of high-value radioisotopes on medical cyclotrons VANCOUVER, August 8, 2018 — ARTMS Products today announced it received CE marking approval for its first-in-class, advanced technology QUANTM Irradiation System TM for producing high-value radioisotopes, such as […]
Vancouver, British Columbia. – December 18, 2017 – Today, ARTMS Products Inc., the leader in the development of novel technologies which enable the production of the world’s most-used diagnostic imaging isotope, announced it has raised US$3 million. The investment comes […]
Today, ARTMS Products, Inc. announced they have signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99TM Irradiation System (QISTM) for radioisotope production. The goal of the partnership is to supply equipment, technologies and research that supports the production […]
ARTMS Products, Inc., a Vancouver-based medical technology company, has won ‘Most Promising Pre-Commercial Technology’ at the BC Tech Technology Impact Awards recently held in Vancouver. Chosen from a very competitive pool of companies from diverse areas of industry, this distinction […]
ARTMS Products, Inc., a Vancouver-based medical technology company, is pleased to announce that it has entered into a strategic partnership with Alliance Medical to enable and demonstrate an alternative, non-reactor supply of technetium-99m (Tc-99m) within the United Kingdom. ARTMS will […]
Researchers at the BC Cancer Agency in Vancouver and TRIUMF, the Canadian national particle and nuclear physics lab, have successfully produced vital supplies of Technetium-99m, a medical imaging isotope, using a retrofitted cyclotron, a type of particle accelerator already in […]
A Canadian-led team says that it has succeeded in proving the feasibility of using particle accelerators instead of nuclear reactors to produce a badly needed medical isotope. If health regulators approve the method, it will place supplies of the crucial […]
The first commercial shipment of medical isotopes produced using a new particle-accelerator-based technique has been made by scientists at the Canadian Light Source (CLS). Molybdenum-99 (Mo-99) decays to create technetium-99m (Tc-99m), which is used to tag radiopharmaceuticals and plays a […]